Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results
Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for fiscal 2023.
The Indianapolis-based pharmaceutical company said its revenues declined 11% year-over-year to $6.96 billion in the first quarter, hurt by lower realized prices and a decline in volumes.
The weak top-line performance translated into a 38% fall in net earnings, on an adjusted basis, to $1.62 per share. Unadjusted profit decreased to $1.34 billion or $1.49 per share from $1.90 billion or $2.10 per share in the first quarter of 2022.
“Core business growth drove solid first-quarter financial results and a strong start for Lilly in 2023, which includes pipeline progress led by positive SURMOUNT-2 data for tirzepatide in obesity,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
Key metrics from Medtronic’s (MDT) Q4 2024 earnings results
Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today. Worldwide revenue was $8.6 billion, up 0.5% on a reported basis and 5.4% on an organic basis. Net income
NVDA Earnings: Nvidia Q1 2025 profit jumps and beats estimates; guides Q2
GPU behemoth NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a multi-fold increase in first-quarter earnings, reflecting continued strong revenue growth. The results also topped expectations. The tech firm's revenues climbed
A few points to note on Lowe’s (LOW) performance in Q1 2024
Shares of Lowe’s Companies Inc. (NYSE: LOW) were down over 1% on Wednesday. The stock has gained 9% over the past 12 months. The home improvement retailer reported its first
